Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An epoxide hydrolase inhibitor reduces neuroinflammation in a mouse model of Alzheimer’s disease
Anamitra Ghosh, Michele M. Comerota, Debin Wan, et al.
Science Translational Medicine (2020) Vol. 12, Iss. 573
Open Access | Times Cited: 102

Showing 1-25 of 102 citing articles:

Oxidative stress: The core pathogenesis and mechanism of Alzheimer’s disease
Renren Bai, Jianan Guo, Xiang‐Yang Ye, et al.
Ageing Research Reviews (2022) Vol. 77, pp. 101619-101619
Closed Access | Times Cited: 422
Movement to the Clinic of Soluble Epoxide Hydrolase Inhibitor EC5026 as an Analgesic for Neuropathic Pain and for Use as a Nonaddictive Opioid Alternative
Bruce D. Hammock, Cindy B. McReynolds, Karen Wagner, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 4, pp. 1856-1872
Open Access | Times Cited: 110
A tetravalent TREM2 agonistic antibody reduced amyloid pathology in a mouse model of Alzheimer’s disease
Peng Zhao, Yuanzhong Xu, Lu-Lin Jiang, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 661
Closed Access | Times Cited: 74
Astrocyte metabolism and signaling pathways in the CNS
Yong-Mei Zhang, Yingbei Qi, Ya-nan Gao, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 47
Astrocytes as a Therapeutic Target in Alzheimer’s Disease–Comprehensive Review and Recent Developments
Mateo Rodríguez-Giraldo, Rodrigo E. González-Reyes, Sofía Ramírez-Guerrero, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13630-13630
Open Access | Times Cited: 64
Direct targeting of sEH with alisol B alleviated the apoptosis, inflammation, and oxidative stress in cisplatin-induced acute kidney injury
Juan Zhang, Zhilin Luan, Xiaokui Huo, et al.
International Journal of Biological Sciences (2022) Vol. 19, Iss. 1, pp. 294-310
Open Access | Times Cited: 47
Molecular Mechanisms Underlying Neuroinflammation Elicited by Occupational Injuries and Toxicants
Dhruba Pathak, Krishnan Sriram
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2272-2272
Open Access | Times Cited: 42
Hepatic soluble epoxide hydrolase activity regulates cerebral Aβ metabolism and the pathogenesis of Alzheimer’s disease in mice
Yu Wu, Jing-Hua Dong, Yongfeng Dai, et al.
Neuron (2023) Vol. 111, Iss. 18, pp. 2847-2862.e10
Open Access | Times Cited: 40
Artificial intelligence for drug discovery and development in Alzheimer's disease
Yunguang Qiu, Feixiong Cheng
Current Opinion in Structural Biology (2024) Vol. 85, pp. 102776-102776
Open Access | Times Cited: 15
Hybrid Membrane‐Coated Nanoparticles for Precise Targeting and Synergistic Therapy in Alzheimer's Disease
Rongrong Lin, Lulu Jin, Yan‐Yan Xue, et al.
Advanced Science (2024) Vol. 11, Iss. 24
Open Access | Times Cited: 15
Dual-Target Inhibitors Based on Acetylcholinesterase: Novel Agents for Alzheimer's Disease
Xingyi Zhao, Qiaoguan Hu, Xiaoqian Wang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116810-116810
Closed Access | Times Cited: 11
Inhibition of soluble epoxide hydrolase ameliorates cerebral blood flow autoregulation and cognition in alzheimer's disease and diabetes-related dementia rat models
Chengyun Tang, Jane J. Border, Huawei Zhang, et al.
GeroScience (2025)
Open Access | Times Cited: 1
Discovery and In Vivo Proof of Concept of a Highly Potent Dual Inhibitor of Soluble Epoxide Hydrolase and Acetylcholinesterase for the Treatment of Alzheimer’s Disease
Sandra Codony, Caterina Pont, Christian Griñán‐Ferré, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 6, pp. 4909-4925
Open Access | Times Cited: 38
Unveiling the Multitarget Anti-Alzheimer Drug Discovery Landscape: A Bibliometric Analysis
Anna Sampietro, F. Javier Pérez-Areales, Paula Felippe Martinez, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 5, pp. 545-545
Open Access | Times Cited: 33
Eicosanoid lipidome activation in post-mortem brain tissues of individuals with APOE4 and Alzheimer’s dementia
Brandon Ebright, Isaac Assante, R Poblete, et al.
Alzheimer s Research & Therapy (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 32
Microglia-Mediated Neurovascular Unit Dysfunction in Alzheimer’s Disease
Wenhao Huang, Qing Xia, Feifei Zheng, et al.
Journal of Alzheimer s Disease (2023) Vol. 94, Iss. s1, pp. S335-S354
Open Access | Times Cited: 23
Dihydroxy-Metabolites of Dihomo-γ-linolenic Acid Drive Ferroptosis-Mediated Neurodegeneration
Morteza Sarparast, Elham Pourmand, Jennifer Hinman, et al.
ACS Central Science (2023) Vol. 9, Iss. 5, pp. 870-882
Open Access | Times Cited: 20
Oleoylethanolamide facilitates PPARα and TFEB signaling and attenuates Aβ pathology in a mouse model of Alzheimer’s disease
Michele M. Comerota, Manasee Gedam, Wen Xiong, et al.
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 18
Cytochrome P450 Metabolism of Polyunsaturated Fatty Acids and Neurodegeneration
Morteza Sarparast, Devon Dattmore, Jamie K. Alan, et al.
Nutrients (2020) Vol. 12, Iss. 11, pp. 3523-3523
Open Access | Times Cited: 42
LILRB2-mediated TREM2 signaling inhibition suppresses microglia functions
Peng Zhao, Yuanzhong Xu, Lu-Lin Jiang, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 25
Cerebrovascular Dysfunction in Alzheimer’s Disease and Transgenic Rodent Models
Xing Fang, Fan Fan, Richard J. Roman
Journal of Experimental Neurology (2024) Vol. 5, Iss. 2, pp. 42-64
Open Access | Times Cited: 6
Multi-tissue profiling of oxylipins reveal a conserved up-regulation of epoxide:diol ratio that associates with white adipose tissue inflammation and liver steatosis in obesity
Charlotte Hateley, Antoni Olona, Laura Halliday, et al.
EBioMedicine (2024) Vol. 103, pp. 105127-105127
Open Access | Times Cited: 6
Inhibition of sEH via stabilizing the level of EETs alleviated Alzheimer's disease through GSK3β signaling pathway
Cheng‐Peng Sun, Xinyue Zhang, Junjun Zhou, et al.
Food and Chemical Toxicology (2021) Vol. 156, pp. 112516-112516
Open Access | Times Cited: 32
Regulatory lipid vicinal diols counteract the biological activity of epoxy fatty acids and can act as biomarkers and mechanisms for disease progression
Cindy B. McReynolds, Bruce D. Hammock, Christophe Morisseau
Pharmacology & Therapeutics (2023) Vol. 248, pp. 108454-108454
Open Access | Times Cited: 12
Lipid mediators generated by the cytochrome P450—Epoxide hydrolase pathway
Timo Frömel, Jiong Hu, Ingrid Fleming
Advances in pharmacology (2023), pp. 327-373
Closed Access | Times Cited: 11
Page 1 - Next Page

Scroll to top